MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'betaseron'. Sat, 03 Sep 2011 02:33:10 +0100 http://www.medworm.com/index.php?rid=4622506&cid=t_210940_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FN2UKxcXoMyU%2F What goes up….will keep going up? Ever since Novartis introduced the first pill to treat multiple sclerosis last year, prices for MS meds have jumped as much as 39 percent. Why? Other drugmakers are charging more for their older treatments in order to maintain revenue in the face of eroding unit sales, Bloomberg News writes. Novartis charges $48,000 for its new Gilenya pill, which prompted Teva Pharmaceutical to raise the price of its Copaxone injectable by 39 percent to $42,300 a year since January 2010. And the cost of MS drugs, which patients generally take for life, is now on par with many cancer meds. Consequently, patients without insurance or who do not qualify for assistance programs may be out of luck. Biogen’s Tysabri costs about $3,566 a month, or $42,788 a year, while... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4622506 Tue, 22 Mar 2011 12:28:26 +0100 4622506 http://www.medworm.com/index.php?rid=4152267&cid=t_210940_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FhA34mJ2aYlk%2F Two months ago, the FDA approved a new type of drug from Novartis called Gilenya to treat relapsing forms of multiple sclerosis and delay the progression of physical disabilities. MS, of course, is hard to treat and since Gilenya is a once-daily pill, the betting is that Novartis has a blockbuster on its hands (back story). But how big? A survey of 43 MS specialists by Leerink Swann finds that Gilenya may grab 13 percent of the US market within one year and 19 percent in two years. If this comes true, Gilenya’s market share by then would exceed all of the competition - Biogen’s Avonex with 18 percent market share; EMD Serono and Pfizer’s Rebif at 15 percent; Bayer’s Betaseron with 9 percent and Biogen’s Tysabri at 8 percent. Only Teva’s Copaxone would be... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4152267 Wed, 10 Nov 2010 16:46:41 +0100 4152267 http://www.medworm.com/index.php?rid=3193805&cid=t_210940_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2F0LUJ4zuNX0s%2F Multiple sclerosis is a neurological disease that strikes most often in adults who are just getting going with their life – they’re establishing their careers, starting families, and they have plans. MS is a disease that can progress slowly, allowing those affected by it to live fairly “normal” lives. Unfortunately, others deteriorate quickly to the point that they can’t care for themselves before they die. MS is seen more in northern countries, so there is a theory that sunlight – or lack of sunlight – plays a role in the development of the disease. Canada has the dubious distinction of having the highest rate of MS in the world. What MS Is In MS, the nerves in the central nervous system (CNS), which is made up of the brain and spinal cord, degene... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=3193805 Thu, 21 Jan 2010 15:53:03 +0100 3193805 http://www.medworm.com/index.php?rid=2712221&cid=t_210940_122_f&fid=34755&url=http%3A%2F%2Fneuropsychological.blogspot.com%2F2009%2F08%2Fbusiness-world-novartis-multiple.html From The Wall Street Journal's Health Blog:AUGUST 17, 2009, 11:12 AM ETNovartis’s Big Plans for Multiple SclerosisBy Jeanne Whalen[snippet]The FDA gave Novartis the green light today to start selling a copy of Betaseron, the multiple sclerosis drug long sold by Bayer.Why would Novartis want to sell somebody else’s years-old drug? Largely to gain experience in the MS marketplace as Novartis plots a future launch of the MS drug FTY720.“It’s a way to build a strong commercial organization and a strong medical organization ahead of FTY,” Novartis pharmaceuticals chief Joe Jimemez told the Health Blog recently.[snippet]Read the full blog entry==========Note: Here is a reference to FTY720:Horga A, & Montalban X. (2008). FTY720 (fingolimod) for relapsing multiple sclerosis. Expert Rev N... BrainBlog blogs http://www.medworm.com/rss/comments.php?id=2712221 Tue, 18 Aug 2009 21:40:00 +0100 2712221 http://www.medworm.com/index.php?rid=2006555&cid=t_210940_117_f&fid=36026&url=http%3A%2F%2Fblog.healthtalk.com%2Fzimney%2Funderstanding-biologics-how-they-differ-from-drugs-and-why-they-cost-more%2F Many of our readers either already have or will in the future encounter the possibility of being treated with a biologic medication. This is because biologics have revolutionized the treatment of such chronic illnesses as rheumatoid arthritis, psoriasis, psoriatic arthritis, Crohn’s disease, and multiple sclerosis, and are widely used in treating a variety of cancers. To name just a few, these products include Enbrel, Humira, Remicade (infliximab), Avonex (inteferon beta-1a), Betaseron (interferon beta-1b), Tysabri, Cimzia (certolizumab pegol), Herceptin (trastuzumab), Rituxan (rituximab), Neupogen (filgrastim), Neulasta (pegfilgrastim) and Leukine (sargramostim). So just what are biologics, how do they differ from more traditional drugs, and why are they so expensive?Although some b... Dr. Z's Medical Report blogs http://www.medworm.com/rss/comments.php?id=2006555 Tue, 02 Dec 2008 18:06:00 +0100 2006555 http://www.medworm.com/index.php?rid=1943575&cid=t_210940_129_f&fid=36038&url=http%3A%2F%2Fblog.healthtalk.com%2Fmultiple-sclerosis%2Flife-with-ms%2Ffinally-a-smaller-needle-for-ms-injections%2F Part of my post-operative treatment was a course of injectable blood thinners for two weeks after my release. When I was in the hospital bed, the nurses came in with a pre-filled syringe and wanted to teach me how to give myself a shot (yes I laughed!). Nobody likes self-injecting it’s just something we’ve all come to terms with. So I prepped myself and took the cap off the needle and laughed again! This needle was so small! It was so thin and so short…why couldn’t MS needles be this small? Apparently, now a MS needle IS this small! The makers of Betaseron (interferon beta-1b) announced last month that they have changed the delivery equipment of their drug (not the formulation) to the thinnest needle in MS injections. This new syringe has a 30-gauge mosquito bite of... Life with MS blogs http://www.medworm.com/rss/comments.php?id=1943575 Sat, 08 Nov 2008 00:14:23 +0100 1943575